Ingalls & Snyder LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.5M Sell
50,681
-1,130
-2% -$78K 0.12% 115
2025
Q1
$3.6M Sell
51,811
-835
-2% -$58K 0.12% 107
2024
Q4
$4.53M Buy
52,646
+961
+2% +$82.7K 0.18% 91
2024
Q3
$6.15M Buy
51,685
+1,037
+2% +$123K 0.24% 75
2024
Q2
$7.23M Buy
50,648
+19,839
+64% +$2.83M 0.31% 60
2024
Q1
$3.96M Sell
30,809
-2,355
-7% -$302K 0.17% 97
2023
Q4
$3.43M Sell
33,164
-1,775
-5% -$184K 0.16% 105
2023
Q3
$3.18M Buy
34,939
+3
+0% +$273 0.15% 101
2023
Q2
$2.83M Hold
34,936
0.14% 112
2023
Q1
$2.78M Hold
34,936
0.14% 105
2022
Q4
$2.36M Hold
34,936
0.13% 116
2022
Q3
$1.74M Hold
34,936
0.1% 139
2022
Q2
$1.95M Hold
34,936
0.1% 138
2022
Q1
$1.94M Hold
34,936
0.09% 154
2021
Q4
$1.96M Hold
34,936
0.09% 157
2021
Q3
$1.68M Sell
34,936
-3,950
-10% -$190K 0.08% 175
2021
Q2
$1.63M Sell
38,886
-50
-0.1% -$2.1K 0.07% 185
2021
Q1
$1.31M Hold
38,936
0.06% 199
2020
Q4
$1.36M Sell
38,936
-2,000
-5% -$69.9K 0.07% 182
2020
Q3
$1.42M Sell
40,936
-2,200
-5% -$76.4K 0.1% 147
2020
Q2
$1.41M Sell
43,136
-1,500
-3% -$49.1K 0.08% 162
2020
Q1
$1.34M Hold
44,636
0.09% 155
2019
Q4
$1.29M Buy
44,636
+7,130
+19% +$206K 0.07% 171
2019
Q3
$970K Sell
37,506
-1,006
-3% -$26K 0.05% 218
2019
Q2
$983K Sell
38,512
-9,780
-20% -$250K 0.05% 221
2019
Q1
$1.26M Sell
48,292
-67,176
-58% -$1.76M 0.06% 192
2018
Q4
$2.66M Sell
115,468
-58,384
-34% -$1.34M 0.14% 125
2018
Q3
$4.1M Buy
+173,852
New +$4.1M 0.17% 109